This announcement does not affect Californias previously approved DSHP funding, including initiatives under the California Advancing and Innovating Medi-Cal (CalAIM) and Behavioral Health Community-Based Organized Networks of Equitable Care and Treatment (BH-CONNECT) 1115 waivers, which remain federally approved and operational
Additionally, consensus guidelines (Ailani et al., 2021) recommend considering preventive pharmacologic therapy for patients experiencing four or more migraine headache days per month, or for those with two or more migraine headache days per month associated with substantial disability despite the use of acute medication
Incontinentia pigmenti with painful subungual tumors: a two-generation study
Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas
Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Merza IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, roszik J, Gibbons DL, Heymach JV, Swisher SG , Bernantchez C, Alatrash G, Hanash S, Molldrem JJ
